Dr. Reddy's Laboratories Limited (FRA:RDDA)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Global Generics	289.55B	245.45B	213.77B	179.17B	147.50B
Global Generics Growth	17.97%	14.82%	19.31%	21.47%	11.56%
Pharmaceutical Services and Active Ingredients (PSAI)	43.24B	40.58B	36.52B	30.74B	38.89B
Pharmaceutical Services and Active Ingredients (PSAI) Growth	6.54%	11.12%	18.80%	-20.95%	22.84%
Others	2.14B	3.91B	3.04B	4.48B	3.34B
Others Growth	-45.35%	28.53%	-32.11%	34.32%	19.96%
Inter-Segment Revenues	-9.39B	-10.78B	-7.45B	-	-
Total	325.54B	279.16B	245.88B	214.39B	189.72B
Total Growth	16.61%	13.54%	14.69%	13.00%	8.66%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
United States	149.35B	135.57B	106.68B	80.56B	76.70B
United States Growth	10.17%	27.07%	32.42%	5.04%	0.89%
India	55.83B	48.47B	50.50B	43.99B	36.25B
India Growth	15.18%	-4.01%	14.81%	21.33%	12.97%
Russia	25.96B	22.30B	21.23B	20.88B	15.82B
Russia Growth	16.40%	5.05%	1.67%	32.01%	-6.41%
Others	94.40B	72.83B	67.47B	68.96B	60.95B
Others Growth	29.62%	7.94%	-2.16%	13.14%	22.93%
Total	325.54B	279.16B	245.88B	214.39B	189.72B
Total Growth	16.61%	13.54%	14.69%	13.00%	8.66%

Source: S&P Global Market Intelligence.